Bernard Saunders Email & Phone Number

Bedminster Nj

Commercial lead responsible for the NATPARA brand. Led the launch team for NATPARA and the brand launch.

Bedminster, Nj

Responsible for the pre-commercialization strategy and market preparation work for the NATPARA brand and also the launch leader for NATPARA. Also was responsible for the pre-commercialization strategy and market preparation for the GATTEX brand. 2015 recipient of the annual President's Award that recognizes employee's who stand out as having extraordinary contributions to the realization of the company's mission and vision while demonstrating the best of the Core Values and Culture. Commercial lead on various strategic committees: FDA Advisory Committee Team, FDA Rapid Response Team, Natural History Registry, Labeling Committee, User Validation Study, OPDP Submissions, Life Cycle Team.

New York, Ny

Commercial leadership role for the osteoporosis franchise including the lead brand lasofoxifene. Lead the cross-functional development team for the three brands in the osteoporosis franchise. Chaired the Global Steering Committee (GSC) which was the cross-functional oversight committee for the brand. As a part of this role, presented brand strategy to the Global Development Review Committee and gained Sr Management endorsement on all projects and major initiatives. Lead all brand activities including launch plan through life cycle recommendations.

East Hanover, N.J.

U.S. responsibility for MIACALCIN Nasal Spray (MNS) in the Mass Market Therapeutic Franchise (Arthritis, Bone, GI, HRT and Inflammation). Responsible for U.S. marketing strategies, tactical implementation and P&L. MNS was the 5th largest Novartis brand and a leader within the therapeutic franchise that faced several new category entrants over time.• Developed and implemented market share strategies in the anti-resorptive market amidst the launch of two competing brands (Actonel/P&G, Fosamax Weekly/Merck). Refreshed brand positioning in the osteoporosis market.• Developed field-centric brand team to drive tactical implementation of new positioning platform and interfaced with VP of the specialty field force Awarded the Novartis Marketing Excellence Award in 2003

Peapack, N.J.

Global responsibilities for the MEDROL Family (SOLU-MEDROL, DEPO-MEDROL and MEDROL Tablets) and ATGAM (transplantation). In addition, responsible for PNU 142731, a development compound in asthma / allergic rhinitis. Responsible for global marketing strategies, tactical implementation and P&L.• Managed the 5th largest brand in the P&U portfolio and contributed to double-digit sales growth• Supported global teams and product life cycle initiatives around the world• Participated and led marketing efforts on development team for asthma compound• Developed Phase IV initiatives and advocacy programs to support key brands and extend product life cycle• Awarded the highest company award (The Upjohn Award) in 1999